Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Media, Education & Engagement
Media & CommunicationAcademic & Trade Publications
Media, Education & Engagement

BioPharma Dive

Data updated

United States

Biopharma trade publication reporting on psychedelic clinical trial outcomes, approvals, setbacks, and market context.

Media & Communication Snapshot

Academic & Trade Publications

Cadence

Daily

Access

Free

Psychedelic Focus

Psychedelic-Adjacent Focus

Verification

Verified

Audience

Industry ProfessionalsInvestors

Coverage Focus

Business & IndustryResearch & SciencePolicy & Legal

Media Notes

BioPharma Dive is a trade news outlet, part of Informa TechTarget's Dive portfolio, covering clinical trials, drug development, regulatory decisions and dealmaking in the biotech and pharmaceutical sectors. Articles are free to read, with daily and weekly email newsletters available on registration. Its audience is industry executives, investors and healthcare professionals, and psychedelic drug developers appear within its broader biopharma coverage.

Verification

Verified

Last Verified

Jul 11, 2026

Primary Media Link

Source Evidence

BioPharma Dive

https://www.biopharmadive.com/

Quick Facts

Type
Other
HQ
United States
Website
Visit